-

Strategies in NMIBC: BCG failure, biomarkers and cost-effective treatments
November 14, 2025Following lively multidisciplinary case discussions in Plenary Session 4 at EMUC25, which covered multiple carcinoma in situ (CIS), as...
00 -

New NMIBC modalities in AS, systemic and intravesical therapies
November 4, 2023Plenary Session 5 “Innovative concepts and new modalities of treatment in urothelial carcinomas” focused on topics such as systemic...